LLY - RBC says Bristol Myers/RayzeBio deal validates Fusion 's approach
2023-12-26 12:16:48 ET
More on Fusion Pharmaceuticals
- Fusion Pharma shares jump following expanded actinium supply deal with BWXT
- Seeking Alpha’s Quant Rating on Fusion Pharmaceuticals
- Historical earnings data for Fusion Pharmaceuticals
- Financial information for Fusion Pharmaceuticals
For further details see:
RBC says Bristol Myers/RayzeBio deal validates Fusion 's approach